Entities / Company
89bio.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
Gone quiet
No new reports in 90+ days-
89bio, a San Francisco-based company, is developing therapies for MASH and utilizes LinkedIn for information.Some support1 report
-
The company 89bio is headquartered in San Francisco.Some support2 reports
-
89bio is developing therapies aimed at treating metabolic dysfunction-associated steatohepatitis (MASH).Some support1 report
-
Leerink partners and Citibank maintained various ratings on 89bio, noting potential benefits from Trump-era tariffs and onshoring.Some support1 report
-
89bio is developing therapies for MASH, and the company's operations are subject to the requirements of Nasdaq Listing Rule 5635(c).Some support1 report
No events began in the chosen period. Widen it, or reset.
Around 89bio this week
News at the entities that move 89bio most-
LinkedIn Mentioned togetherBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves 89bio
Connections
The 1 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
LinkedIn Mentioned together
89bio uses LinkedIn as a platform to monitor industry information.
History
Events by the month they beganJune 2026
5 events- 89bio, a San Francisco-based company, is developing therapies for MASH and utilizes LinkedIn for information.
- The company 89bio is headquartered in San Francisco.
- 89bio is developing therapies aimed at treating metabolic dysfunction-associated steatohepatitis (MASH).
- Leerink partners and Citibank maintained various ratings on 89bio, noting potential benefits from Trump-era tariffs and onshoring.
- 89bio is developing therapies for MASH, and the company's operations are subject to the requirements of Nasdaq Listing Rule 5635(c).